Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bortezomib. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel solid-phase method for Bortezomib (CN104211758B) offers high purity and simplified purification, ensuring reliable supply chain for proteasome inhibitors.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Advanced purification technology for bortezomib ensuring high purity and yield. Optimized for commercial scale-up and supply chain reliability in pharmaceutical manufacturing.
Patent CN102675415B details a novel copper-catalyzed route for bortezomib intermediates, offering enhanced scalability and cost efficiency for API manufacturing.
Patent CN103897028A details a heavy-metal-free synthesis of Bortezomib, offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Novel 8-step route for Bortezomib using isobutylboronic acid, eliminating column chromatography for cost-effective manufacturing.
Patent CN103030656B details a novel catalytic route for bortezomib, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103044467A details a scalable route for R-(1-amino-3-methyl)butyl pinacol borate, eliminating cryogenic conditions and column chromatography for cost-effective manufacturing.
Novel convergent route for bortezomib manufacturing ensures over 99.8 percent purity. Reduces racemization risks and simplifies hydrolysis for reliable supply chain partners.
Advanced patent CN104860975B enables cost-effective bortezomib intermediate production. Enhanced yield and purity for reliable pharmaceutical supply chains.
Patent CN102659919A details a cost-effective bortezomib synthesis using (R)-tert-butylsulfinamide, offering high purity and scalable manufacturing for global supply chains.